Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)

• Kornelis J. J. van Hateren ,

  * E-mail: k.j.j.van.hateren@isala.nl

  Affiliation Diabetes Centre, Isala, Zwolle, the Netherlands

  ⨯
• Gijs W. D. Landman,

  Affiliations Diabetes Centre, Isala, Zwolle, the Netherlands, Department of Internal Medicine, Gelre hospital, Apeldoorn, the Netherlands

  ⨯
• Jarinke F. H. Arnold,

  Affiliation Diabetes Centre, Isala, Zwolle, the Netherlands

  ⨯
• Hanneke Joosten,

  Affiliations Diabetes Centre, Isala, Zwolle, the Netherlands, University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, the Netherlands

  ⨯
• Klaas H. Groenier,

  Affiliations Diabetes Centre, Isala, Zwolle, the Netherlands, University of Groningen, University Medical Center Groningen, Department of General Practice, Groningen, the Netherlands

  ⨯
• Gerjan J. Navis,

  Affiliation University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, the Netherlands

  ⨯
• Andrea Sparwasser,

  Affiliation Research Department, B.R.A.H.M.S GmbH (Thermo Fisher Scientific), Hennigsdorf/Berlin, Germany

  ⨯
• Stephan J. L. Bakker,

  Affiliation University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, the Netherlands

  ⨯
• Henk J. G. Bilo,

  Affiliations Diabetes Centre, Isala, Zwolle, the Netherlands, University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, the Netherlands, Department of Internal Medicine, Isala, Zwolle, the Netherlands

  ⨯
• Nanne Kleefstra

  Affiliations Diabetes Centre, Isala, Zwolle, the Netherlands, University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, the Netherlands, Langerhans Medical Research Group, Zwolle, the Netherlands

  ⨯